According to the patient’s condition, intravenous atezolizumab and bevacizumab were given within 3 weeks after TAE and HAIC. Atezolizumab was given intravenously at the recommended dose of 1200 mg/time, followed by intravenous bevacizumab at 15 mg/kg/time. This regimen was administered every 3 weeks until disease progression or intolerable toxicity.
Protocol detail
Combination Immunotherapy after TAE and HAIC
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization :
Other organizations : The First Affiliated Hospital, Sun Yat-sen University, Sun Yat-sen University, Sun Yat-sen University Cancer Center
Top 5 similar protocols
Variable analysis
independent variables
- Intravenous administration of atezolizumab
- Intravenous administration of bevacizumab
- Disease progression
- Intolerable toxicity
- Administration of atezolizumab and bevacizumab within 3 weeks after TAE and HAIC
- Atezolizumab administration at the recommended dose of 1200 mg/time
- Bevacizumab administration at 15 mg/kg/time
- Administration of the regimen every 3 weeks
- No positive or negative controls were explicitly mentioned.
Annotations
Based on most similar protocols
Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.
Sign up for free or login to display all annotations
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!